Bladder cancer is a prevalent malignancy with limited therapeutic options, particularly for
patients who are unresponsive to Bacillus Calmette-Guérin (BCG). The approval of …

Introduction Gene therapy aims to alter the biological properties of cells through the
therapeutic delivery of nucleotides to treat a disease. Although originally developed to treat …

Bladder cancer poses considerable therapeutic difficulties owing to its elevated rates of
recurrence and the constraints of existing treatment methods. This study examines the …

Introduction Nadofaragene firadenovec (Ad-IFNα/Syn3) is now approved for BCG-
unresponsive bladder cancer (BLCA). IFNα is a pleiotropic cytokine that causes direct tumor …

Stem cells have been widely applied in regenerative and therapeutic medicine for their
unique regenerative properties. Although much research has shown their potential, it …

Introduction Approximately 75% of bladder cancer cases are non-muscle invasive at
diagnosis. Drug development for non-muscle invasive bladder cancer (NMIBC) has …

Objetivo: Avaliar a efetividade da imunoterapia em uma ampla gama de neoplasias.
Métodos: Estudo cienciométrico utilizando as bases de dados PubMed, Scientific Electronic …

Gene therapy involves either the direct introduction of genetic material (DNA or RNA) into
the host cell (or organ), known as in vivo gene therapy, the re-introduction of the modified …